If you've ever had a urinary tract infection (UTI), you know how miserable it can be: the burning, the itching, the constant trips to the bathroom. Now imagine going through round after round of ...

Ahead of an Antimicrobial Drugs Advisory Committee meeting on Monday, FDA reviewers voiced ongoing concerns about the benefits versus risks of a novel oral antibiotic for the treatment of ...

Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial treatment option for drug-resistant urinary tract infections (UTIs). In clinical trials, ...

Cefdinir showed nearly double the treatment failure rate compared to cephalexin in outpatient uUTI management. Cefdinir's lower bioavailability and urinary excretion contribute to its reduced efficacy ...

First-line treatment of uncomplicated urinary tract infection (UTI) in adolescent and adult English women often fails to follow national guidelines, potentially necessitating more prescriptions and ...

Firsts are freaky, but they don’t have to be. In Her Campus’s series My First Time, we’re answering the burning questions you might be uncomfortable asking about IRL. In this article, we tackle what ...

Faster diagnosis: The RMD AST test can pinpoint UTI-causing bacteria and drug sensitivity in just six hours, compared to days for standard lab work. High accuracy: Trials found the test matched ...

More than 400 million people experience a urinary tract infection every year, and some epidemiological studies estimate that ...